REG4 and ovarian carcinoma: Either REG4 overexpression or rhREG4 treatment promoted proliferation, G2/S progression, anti-apoptosis, migration, invasion, and cisplatin and paclitaxel resistance in ovarian cancer cells (Chen et al., 2015; Xiang et al., 2022).